These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37718272)

  • 41. A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids.
    Frude E; McKay FH; Dunn M
    Harm Reduct J; 2020 Jun; 17(1):42. PubMed ID: 32532347
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs.
    Mestria S; Odoardi S; Frison G; Strano Rossi S
    Drug Test Anal; 2021 Apr; 13(4):876-882. PubMed ID: 33245851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 'Trafficking' or 'personal use': do people who regularly inject drugs understand Australian drug trafficking laws?
    Hughes CE; Ritter A; Cowdery N; Sindicich N
    Drug Alcohol Rev; 2014 Nov; 33(6):658-66. PubMed ID: 25041655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs).
    Nourse G; Fraser S; Moore D
    Health Sociol Rev; 2024 Jan; ():1-17. PubMed ID: 38286142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview.
    Coomber R; Moyle L; Belackova V; Decorte T; Hakkarainen P; Hathaway A; Laidler KJ; Lenton S; Murphy S; Scott J; Stefunkova M; van de Ven K; Vlaemynck M; Werse B
    Int J Drug Policy; 2018 Aug; 58():93-103. PubMed ID: 29890504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review.
    Brennan R; Wells JSG; Van Hout MC
    Health Soc Care Community; 2017 Sep; 25(5):1459-1531. PubMed ID: 26806443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom.
    Mooney R; Simonato P; Ruparelia R; Roman-Urrestarazu A; Martinotti G; Corazza O
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders.
    Fabresse N; Gheddar L; Kintz P; Knapp A; Larabi IA; Alvarez JC
    Forensic Sci Int; 2021 May; 322():110771. PubMed ID: 33838562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
    Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network.
    McVeigh J; Hearne E; Boardley I; Bates G; Hope V; Ralphs R; Van Hout MC
    Harm Reduct J; 2021 Oct; 18(1):107. PubMed ID: 34657627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of anabolic androgenic steroids and polypharmacy: a review of the literature.
    Dodge T; Hoagland MF
    Drug Alcohol Depend; 2011 Apr; 114(2-3):100-9. PubMed ID: 21232881
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation.
    van de Ven K; Koenraadt R
    Int J Drug Policy; 2017 Dec; 50():48-55. PubMed ID: 29028563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poly-drug trafficking: Estimating the scale, trends and harms at the Australian border.
    Hughes CE; Chalmers J; Bright DA; McFadden M
    Int J Drug Policy; 2016 May; 31():80-9. PubMed ID: 26860325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pilot wastewater-based epidemiology assessment of anabolic steroid use in Queensland, Australia.
    Shimko KM; O'Brien JW; Barron L; Kayalar H; Mueller JF; Tscharke BJ; Choi PM; Jiang H; Eaglesham G; Thomas KV
    Drug Test Anal; 2019 Jul; 11(7):937-949. PubMed ID: 30901160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Examining supply changes in Australia's cocaine market.
    Hughes CE; Chalmers J; Bright DA; Matthew-Simmons F; Sindicich N
    Drug Alcohol Rev; 2012 May; 31(3):263-72. PubMed ID: 21906192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polydrug use and polydrug markets amongst image and performance enhancing drug users: Implications for harm reduction interventions and drug policy.
    Salinas M; Floodgate W; Ralphs R
    Int J Drug Policy; 2019 May; 67():43-51. PubMed ID: 30884355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Health Authority Control Measures Aimed at Reducing the Illicit Use of Anabolic-Androgenic Steroids.
    Vázquez-Mourelle R; Carracedo-Martinez E; Figueiras A
    Eur Addict Res; 2018; 24(1):28-36. PubMed ID: 29448243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence of use and users of image- and performance-enhancing drugs in sports in Switzerland: a scoping literature review and implications for Swiss drug policy.
    Kruijver M; Bruggmann P; Magnolini R
    Swiss Med Wkly; 2023 May; 153():40080. PubMed ID: 37245119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Sports, use of performance enhancing drugs and addiction. A conceptual and epidemiological review].
    Franques P; Auriacombe M; Tignol J
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():37-49. PubMed ID: 11965097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.